BioPharma Dive - Latest News

FDA misses approval deadline for Novavax’s COVID-19 vaccine

The delayed decision comes amid a major organizational shakeup that included the departure of top vaccine official Peter Marks.

Apr 3, 2025 - 15:41
 0
FDA misses approval deadline for Novavax’s COVID-19 vaccine

The delayed decision comes amid a major organizational shakeup that included the departure of top vaccine official Peter Marks.

Read More

Tags:

Previous Article

Vertex Pharmaceuticals: How a Human-Centric Digital Strategy Transforms Supply C...

Next Article

Human medicines European public assessment report (EPAR): MabThera, rituximab, D...

Related Posts

23andMe files for bankruptcy as CEO Anne Wojcicki resigns

23andMe files for bankruptcy as CEO Anne Wojcicki resigns

Mar 24, 2025  0

Following FDA cuts, Trump nominee Makary vows ‘independent’ staff review

Following FDA cuts, Trump nominee Makary vows ‘independ...

Mar 6, 2025  0

GSK, Pfizer sales of RSV shots slow as vaccination rates ebb

GSK, Pfizer sales of RSV shots slow as vaccination rate...

Feb 9, 2025  0